Inactivation of Sirtuin2 protects mice from acetaminophen-induced liver injury: possible involvement of ER stress and S6K1 activation
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Acetaminophen (APAP) overdose can cause hepatotoxicity by inducing mitochondrial damage and subsequent necrosis in hepatocytes. Sirtuin2 (Sirt2) is an NAD+-dependent deacetylase that regulates several biological processes, including hepatic gluconeogenesis, as well as inflammatory pathways. We show that APAP decreases the expression of Sirt2. Moreover, the ablation of Sirt2 attenuates APAP-induced liver injuries, such as oxidative stress and mitochondrial damage in hepatocytes. We found that Sirt2 deficiency alleviates the APAP-mediated endoplasmic reticulum (ER) stress and phosphorylation of the p70 ribosomal S6 kinase 1 (S6K1). Moreover, Sirt2 interacts with and deacetylates S6K1, followed by S6K1 phosphorylation induction. This study elucidates the molecular mechanisms underlying the protective role of Sirt2 inactivation in APAP-induced liver injuries.
Abstract
Acetaminophen (APAP) overdose can cause hepatotoxicity by inducing mitochondrial damage and subsequent necrosis in hepatocytes. Sirtuin2 (Sirt2) is an NAD+-dependent deacetylase that regulates several biological processes, including hepatic gluconeogenesis, as well as inflammatory pathways. We show that APAP decreases the expression of Sirt2. Moreover, the ablation of Sirt2 attenuates APAP-induced liver injuries, such as oxidative stress and mitochondrial damage in hepatocytes. We found that Sirt2 deficiency alleviates the APAP-mediated endoplasmic reticulum (ER) stress and phosphorylation of the p70 ribosomal S6 kinase 1 (S6K1). Moreover, Sirt2 interacts with and deacetylates S6K1, followed by S6K1 phosphorylation induction. This study elucidates the molecular mechanisms underlying the protective role of Sirt2 inactivation in APAP-induced liver injuries.
참고문헌 (41)
- Ghabril M, "Drug-induced liver injury : a clinical update", Curr Opin Gastroenterol, 26, pp.222~226 (2010)
- James LP, "Acetaminophen-induced hepatotoxicity", Drug Metab Dispos, 31, pp.1499~1506 (2003)
- Ni HM, "Targeting autophagy for the treatment of liver diseases", Pharmacol Res, 66, pp.463~474 (2012)
- Hinson JA, "Mechanisms of acetaminophen-induced liver necrosis", Handb Exp Pharmacol, pp.369~405 (2010)
- Copple IM, "The hepatotoxic metabolite of acetaminophen directly activates the Keap1-Nrf2 cell defense system", Hepatology, 48, pp.1292~1301 (2008)
- Nagy G, "Acetaminophen induces ER dependent signaling in mouse liver", Arch Biochem Biophys, 459, pp.273~279 (2007)
- Foufelle F, "Role of endoplasmic reticulum stress in drug-induced toxicity", Pharmacol Res Perspect, 4, pp.e00211~ (2016)
- Frye RA, "Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins", Biochem Biophys Res Commun, 273, pp.793~798 (2000)
- Morris BJ, "Seven sirtuins for seven deadly diseases of aging", Free Radic Biol Med, 56, pp.133~171 (2013)
- Houtkooper RH, "Sirtuins as regulators of metabolism and healthspan", Nat Rev Mol Cell Biol, 13, pp.225~238 (2012)
- Gomes P, "Emerging Role of Sirtuin 2 in the Regulation of Mammalian Metabolism", Trends Pharmacol Sci, 36, pp.756~768 (2015)
- Craig DG, "Overdose pattern and outcome in paracetamol-induced acute severe hepatotoxicity", Br J Clin Pharmacol, 71, pp.273~282 (2011)
- Outeiro TF, "Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease", Science, 317, pp.516~519 (2007)
- Rumpf T, "Selective Sirt2 inhibition by ligand-induced rearrangement of the active site", Nat Commun, 6, pp.6263~ (2015)
- Luthi-Carter R, "SIRT2inhibition achieves neuroprotection by decreasing sterol biosynthesis", Proc Natl Acad Sci U S A, 107, pp.7927~7932 (2010)
- Hu J, "Low Dose Acetaminophen Induces Reversible Mitochondrial Dysfunction Associated with Transient c-Jun N-Terminal Kinase Activation in Mouse Liver", Toxicol Sci, 150, pp.204~215 (2016)
- Ni HM, "Zonated induction of autophagy and mitochondrial spheroids limits acetaminophen-induced necrosis in the liver", Redox Biol, 1, pp.427~432 (2013)
- Lorz C, "Paracetamol-induced renal tubular injury : a role for ER stress", J Am Soc Nephrol, 15, pp.380~389 (2004)
- Uzi D, "CHOP is a critical regulator of acetaminophen-induced hepatotoxicity", J Hepatol, 59, pp.495~503 (2013)
- Kalinec GM, "Acetaminophen and NAPQI are toxic to auditory cells via oxidative and endoplasmic reticulum stress-dependent pathways", Hear Res, 313, pp.26~37 (2014)
- Bertolotti A, "Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response", Nat Cell Biol, 2, pp.326~332 (2000)
- Dong G, "mTOR contributes to ER stress and associated apoptosis in renal tubular cells", Am J Physiol Renal Physiol, 308, pp.F267~F274 (2015)
- Wu M, "Acetaminophen improves protein translational signaling in aged skeletal muscle", Rejuvenation Res, 13, pp.571~579 (2010)
- Hong S, "Cross-talk between sirtuin and mammalian target of rapamycin complex 1(mTORC1)signaling in the regulation of S6 kinase 1(S6K1)phosphorylation", J Biol Chem, 289, pp.13132~13141 (2014)
- Rack JG, "Constitutive nuclear localization of an alternatively spliced sirtuin-2 isoform", J Mol Biol, 426, pp.1677~1691 (2014)
- Mangas-Sanjuan V, "Tubulin acetylation promoting potency and absorption efficacy of deacetylase inhibitors", Br J Pharmacol, 172, pp.829~840 (2015)
- Chopra V, "The sirtuin 2inhibitor AK-7 is neuroprotective in Huntington's disease mouse models", Cell Rep, 2, pp.1492~1497 (2012)
- Wu FL, "Targeting endoplasmic reticulum stress in liver disease", Expert Rev Gastroenterol Hepatol, 10, pp.1041~1052 (2016)
- Malhi H, "Endoplasmic reticulum stress in liver disease", J Hepatol, 54, pp.795~809 (2011)
- Hay N, "Upstream and downstream of mTOR", Genes Dev, 18, pp.1926~1945 (2004)
- Ni HM, "Activation of autophagy protects against acetaminophen-induced hepatotoxicity", Hepatology, 55, pp.222~232 (2012)
- Borude P, "Pleiotropic Role of p53 in Injury and Liver Regeneration after Acetaminophen Overdose", Am J Pathol, 188, pp.1406~1418 (2018)
- Chen W, "Tethering Interleukin-22 to Apolipoprotein A-I Ameliorates Mice from Acetaminophen-induced Liver Injury", Theranostics, 7, pp.4135~4148 (2017)
- Wang J, "Sirtuin 2 aggravates postischemic liver injury by deacetylating mitogen-activated protein kinase phosphatase-1", Hepatology, 65, pp.225~236 (2017)
- Arteaga M, "Inhibition of SIRT2 suppresses hepatic fibrosis", Am J Physiol Gastrointest Liver Physiol, 310, pp.G1155~G1168 (2016)
- Lu Z, "SIRT3-dependent deacetylation exacerbates acetaminophen hepatotoxicity", EMBO Rep, 12, pp.840~846 (2011)
- Inoue T, "SIRT2 knockdown increases basal autophagy and prevents postslippage death by abnormally prolonging the mitotic arrest that is induced by microtubule inhibitors", FEBS J, 281, pp.2623~2637 (2014)
- Park SH, "SIRT2 is a tumor suppressor that connects aging, acetylome, cell cycle signaling, and carcinogenesis", Transl Cancer Res, 1, pp.15~21 (2012)
- Kim HS, "SIRT2maintains genome integrity and suppresses tumorigenesis through regulating APC", C activity, 2011, pp.20, 487~499
- Nie H, "Silencing of SIRT2induces cell death and a decrease in the intracellular ATP level of PC12 cells", Int J Physiol Pathophysiol Pharmacol, 3, pp.65~70 (2011)
- Hoffmann G, "A novel sirtuin 2(SIRT2)inhibitor with p53-dependent pro-apoptotic activity in non-small cell lung cancer", J Biol Chem, 289, pp.5208~5216 (2014)
